V-Guard Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 16, 2025, 10:08 am

Quick Insight

V-Guard Industries Ltd, with a market capitalization of ₹15,694 Cr. and a P/E ratio of 67.0, reflects an optimistic market sentiment towards the company in the domestic appliances industry. The company's ROE of 13.6% and ROCE of 17.2% indicate efficient capital utilization. With a healthy OPM of 7% and a strong net profit of ₹260 Cr., V-Guard demonstrates operational effectiveness. The company's diversified shareholding pattern, with promoters holding 54.42% and FIIs and DIIs at 13.90% and 20.16% respectively, provides stability. Furthermore, V-Guard's comfortable ICR of 21.79x and robust P/BV of 7.43x suggest strong financial health and growth potential. In conclusion, V-Guard Industries appears well-positioned for sustained growth and value creation in the domestic appliances sector.

Competitors of V-Guard Industries Ltd

All Competitor Stocks of V-Guard Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:30 am

Below is a detailed analysis of the quarterly data for V-Guard Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,406.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,480.00 Cr. (Mar 2025) to 1,406.00 Cr., marking a decrease of 74.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,313.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,359.00 Cr. (Mar 2025) to 1,313.00 Cr., marking a decrease of 46.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 27.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Mar 2025) to 7.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 102.00 Cr. (Mar 2025) to 76.00 Cr., marking a decrease of 26.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 26.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 22.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.28. The value appears to be declining and may need further review. It has decreased from 1.79 (Mar 2025) to 1.28, marking a decrease of 0.51.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:50 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:06 pm

Below is a detailed analysis of the balance sheet data for V-Guard Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,955.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,725.00 Cr. (Mar 2024) to 1,955.00 Cr., marking an increase of 230.00 Cr..
• For Borrowings, as of Mar 2025, the value is 77.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 356.00 Cr. (Mar 2024) to 77.00 Cr., marking a decrease of 279.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 964.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 762.00 Cr. (Mar 2024) to 964.00 Cr., marking an increase of 202.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,039.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,886.00 Cr. (Mar 2024) to 3,039.00 Cr., marking an increase of 153.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 465.00 Cr.. The value appears strong and on an upward trend. It has increased from 435.00 Cr. (Mar 2024) to 465.00 Cr., marking an increase of 30.00 Cr..
• For CWIP, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 899.00 Cr.. The value appears to be declining and may need further review. It has decreased from 919.00 Cr. (Mar 2024) to 899.00 Cr., marking a decrease of 20.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,626.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,496.00 Cr. (Mar 2024) to 1,626.00 Cr., marking an increase of 130.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,039.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,886.00 Cr. (Mar 2024) to 3,039.00 Cr., marking an increase of 153.00 Cr..

Notably, the Reserves (1,955.00 Cr.) exceed the Borrowings (77.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for V-Guard Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.17. This value is within the healthy range. It has increased from 5.89 (Mar 24) to 7.17, marking an increase of 1.28.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.14. This value is within the healthy range. It has increased from 5.88 (Mar 24) to 7.14, marking an increase of 1.26.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.39. This value is within the healthy range. It has increased from 7.79 (Mar 24) to 9.39, marking an increase of 1.60.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.14. It has increased from 41.76 (Mar 24) to 48.14, marking an increase of 6.38.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.14. It has increased from 41.76 (Mar 24) to 48.14, marking an increase of 6.38.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 127.99. It has increased from 111.80 (Mar 24) to 127.99, marking an increase of 16.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has increased from 10.61 (Mar 24) to 12.26, marking an increase of 1.65.
• For PBIT / Share (Rs.), as of Mar 25, the value is 10.06. This value is within the healthy range. It has increased from 8.74 (Mar 24) to 10.06, marking an increase of 1.32.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.50. This value is within the healthy range. It has increased from 7.83 (Mar 24) to 9.50, marking an increase of 1.67.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.20. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 7.20, marking an increase of 1.27.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.20. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 7.20, marking an increase of 1.27.
• For PBDIT Margin (%), as of Mar 25, the value is 9.57. This value is below the healthy minimum of 10. It has increased from 9.48 (Mar 24) to 9.57, marking an increase of 0.09.
• For PBIT Margin (%), as of Mar 25, the value is 7.86. This value is below the healthy minimum of 10. It has increased from 7.82 (Mar 24) to 7.86, marking an increase of 0.04.
• For PBT Margin (%), as of Mar 25, the value is 7.42. This value is below the healthy minimum of 10. It has increased from 7.00 (Mar 24) to 7.42, marking an increase of 0.42.
• For Net Profit Margin (%), as of Mar 25, the value is 5.62. This value is within the healthy range. It has increased from 5.30 (Mar 24) to 5.62, marking an increase of 0.32.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.62. This value is below the healthy minimum of 8. It has increased from 5.30 (Mar 24) to 5.62, marking an increase of 0.32.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.95. This value is below the healthy minimum of 15. It has increased from 14.19 (Mar 24) to 14.95, marking an increase of 0.76.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.93. This value is within the healthy range. It has increased from 17.59 (Mar 24) to 18.93, marking an increase of 1.34.
• For Return On Assets (%), as of Mar 25, the value is 9.39. This value is within the healthy range. It has increased from 8.14 (Mar 24) to 9.39, marking an increase of 1.25.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.00, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.16 (Mar 24) to 0.01, marking a decrease of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.72. It has increased from 1.60 (Mar 24) to 1.72, marking an increase of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 1.75, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.77, marking a decrease of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 4. It has increased from 2.15 (Mar 24) to 2.20, marking an increase of 0.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 21.88 (Mar 24) to 0.00, marking a decrease of 21.88.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.65 (Mar 24) to 0.00, marking a decrease of 16.65.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 78.12 (Mar 24) to 0.00, marking a decrease of 78.12.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.35 (Mar 24) to 0.00, marking a decrease of 83.35.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 21.79. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 21.79, marking an increase of 10.14.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.80. This value is within the healthy range. It has increased from 7.51 (Mar 24) to 13.80, marking an increase of 6.29.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15,530.52. It has increased from 14,631.85 (Mar 24) to 15,530.52, marking an increase of 898.67.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.78. This value is within the healthy range. It has decreased from 3.01 (Mar 24) to 2.78, marking a decrease of 0.23.
• For EV / EBITDA (X), as of Mar 25, the value is 29.08. This value exceeds the healthy maximum of 15. It has decreased from 31.76 (Mar 24) to 29.08, marking a decrease of 2.68.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 2.96 (Mar 24) to 2.79, marking a decrease of 0.17.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 78.11 (Mar 24) to 0.00, marking a decrease of 78.11.
• For Price / BV (X), as of Mar 25, the value is 7.43. This value exceeds the healthy maximum of 3. It has decreased from 7.94 (Mar 24) to 7.43, marking a decrease of 0.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 2.96 (Mar 24) to 2.79, marking a decrease of 0.17.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness